TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck

  1. Rubió-Casadevall, J.
  2. Cirauqui Cirauqui, B.
  3. Martinez Trufero, J.
  4. Plana Serrahima, M.
  5. García Castaño, A.
  6. Carral Maseda, A.
  7. Iglesias Docampo, L.
  8. Pérez Segura, P.
  9. Ceballos Lenza, I.
  10. Gutiérrez Calderón, V.
  11. Fuster Salvà, J.
  12. Pena Álvarez, C.
  13. Hernandez, I.
  14. del Barco Morillo, E.
  15. Chaves Conde, M.
  16. Martínez Galán, J.
  17. Durán Sánchez, M.
  18. Quiroga, V.
  19. Ortega, E.
  20. Mesia, R.
Revue:
Frontiers in Oncology

ISSN: 2234-943X

Année de publication: 2023

Volumen: 13

Type: Article

DOI: 10.3389/FONC.2023.1226939 GOOGLE SCHOLAR lock_openAccès ouvert editor